Trajenta 5 Tablet — Uses, Dosage & Benefits

Linagliptin 5 mg

Linagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP) by preventing their breakdown. This increases insulin release in a glucose-dependent manner and reduces glucagon secretion, lowering blood glucose with a low risk of hypoglycaemia when used alone.

Oral tablet: typically 1 tablet (5 mg) once daily, with or without food, at the same time each day. Swallow whole with water; continue diet and exercise as advised. Dose adjustments may be needed when used with insulin or sulfonylureas to reduce hypoglycaemia risk.

Always follow your doctor's prescription. Do not self-medicate.